10 20 30 40 50 60 70 80 1CQH - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER COMPLEX (ELECTRON TRANSPORT/PEPTIDE) 02-APR-96 1CQH
TITLE HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE TITLE 2 INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, TITLE 3 C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TITLE 4 TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 TITLE 5 SUBUNIT OF NFKB), NMR, MINIMIZED AVERAGE STRUCTURE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIOREDOXIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: REF-1 PEPTIDE; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB; COMPND 10 EC: 4.2.99.18; COMPND 11 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: POTENTIAL; SOURCE 6 MOL_ID: 2
KEYWDS COMPLEX, ELECTRON TRANSPORT/PEPTIDE, COMPLEX (ELECTRON KEYWDS 2 TRANSPORT/PEPTIDE) COMPLEX
EXPDTA SOLUTION NMR
AUTHOR G.M.CLORE,J.QIN,A.M.GRONENBORN
REVDAT 2 24-FEB-09 1CQH 1 VERSN REVDAT 1 01-AUG-96 1CQH 0
JRNL AUTH J.QIN,G.M.CLORE,W.P.KENNEDY,J.KUSZEWSKI, JRNL AUTH 2 A.M.GRONENBORN JRNL TITL THE SOLUTION STRUCTURE OF HUMAN THIOREDOXIN JRNL TITL 2 COMPLEXED WITH ITS TARGET FROM REF-1 REVEALS JRNL TITL 3 PEPTIDE CHAIN REVERSAL. JRNL REF STRUCTURE V. 4 613 1996 JRNL REFN ISSN 0969-2126 JRNL PMID 8736558 JRNL DOI 10.1016/S0969-2126(96)00065-2
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.QIN,G.M.CLORE,W.M.KENNEDY,J.R.HUTH,A.M.GRONENBORN REMARK 1 TITL SOLUTION STRUCTURE OF HUMAN THIOREDOXIN IN A MIXED REMARK 1 TITL 2 DISULFIDE INTERMEDIATE COMPLEX WITH ITS TARGET REMARK 1 TITL 3 PEPTIDE FROM THE TRANSCRIPTION FACTOR NF KAPPA B REMARK 1 REF STRUCTURE V. 3 289 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.QIN,G.M.CLORE,A.M.GRONENBORN REMARK 1 TITL THE HIGH-RESOLUTION THREE-DIMENSIONAL SOLUTION REMARK 1 TITL 2 STRUCTURES OF THE OXIDIZED AND REDUCED STATES OF REMARK 1 TITL 3 HUMAN THIOREDOXIN REMARK 1 REF STRUCTURE V. 2 503 1994 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.D.FORMAN-KAY,G.M.CLORE,P.T.WINGFIELD, REMARK 1 AUTH 2 A.M.GRONENBORN REMARK 1 TITL HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF REMARK 1 TITL 2 REDUCED RECOMBINANT HUMAN THIOREDOXIN IN SOLUTION REMARK 1 REF BIOCHEMISTRY V. 30 2685 1991 REMARK 1 REFN ISSN 0006-2960
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURES ARE CALCULATED USING THE HYBRID METRIC REMARK 3 MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING REMARK 3 METHOD DESCRIBED BY: NILGES, M., CLORE, G.M. & REMARK 3 GRONENBORN, A.M. (1988) FEBS LETT 229, 317 - 324. REMARK 3 MODIFIED TO INCORPORATE COUPLING CONSTANT (GARRETT ET AL. REMARK 3 (1994) J. MAGN. RESON SERIES B 104 99 - 103), CARBON REMARK 3 CHEMICAL SHIFT (KUSZEWSKI ET AL. (1995) J. MAGN. RESON. REMARK 3 SERIES B 106, 92 - 96), AND PROTON CHEMICAL SHIFT REMARK 3 (KUSZEWSKI ET AL. (1995) J. MAGN. RESON SERIES B 107, REMARK 3 293 - 297) RESTRAINTS, AND A CONFORMATIONAL DATABASE REMARK 3 POTENTIAL TERM (KUSZEWSKI, GRONENBORN & CLORE (1996) REMARK 3 PROTEIN SCIENCE IN PRESS). ALL STRUCTURAL STATISTICS ARE REMARK 3 GIVEN IN THE REFERENCE. REMARK 3 REMARK 3 THE 3D STRUCTURE OF THE HUMAN THIOREDOXIN-NFKB PEPTIDE REMARK 3 COMPLEX IN SOLUTION BY NMR IS BASED ON 3213 EXPERIMENTAL REMARK 3 RESTRAINTS COMPRISING: REMARK 3 2581 STRUCTURE USEFUL INTERPROTON DISTANCE RESTRAINTS REMARK 3 36 RESTRAINTS FOR 18 BACKBONE H-BONDS REMARK 3 321 TORSION ANGLE RESTRAINTS (104 PHI, 76 PSI, 78 CHI1, REMARK 3 AND 30 CHI2 FOR HUMAN THIOREDOXIN, AND 11 PHI, REMARK 3 9 PSI, 9 CHI1, AND 4 CHI2 ANGLES FOR THE REF-1 REMARK 3 PEPTIDE REMARK 3 86 HN-HALPHA THREE-BOND COUPLING CONSTANTS REMARK 3 100 13CALPHA AND 97 13CB CHEMICAL SHIFT RESTRAINTS. REMARK 3 442 1H CHEMICAL SHIFT RESTRAINTS (MADE UP OF 113 CAH, REMARK 3 67 METHYL GROUPS AND 262 OTHER NON-EXCHANGEABLE REMARK 3 PROTONS). REMARK 3 THE BREAKDOWN OF THE INTERPROTON DISTANCE RESTRAINTS IS AS REMARK 3 FOLLOWS: REMARK 3 INTRAMOLECULAR HTRX RESTRAINTS: REMARK 3 534 SEQUENTIAL REMARK 3 539 SHORT RANGE (1 < |I-J|<=5) REMARK 3 688 LONG RANGE (|I-J|>5) REMARK 3 682 INTRARESIDUE REMARK 3 INTRAMOLECULAR PEPTIDE RESTRAINTS: 83 REMARK 3 INTERMOLECULAR HTRX-NFKB: 55 REMARK 3 REMARK 3 THE STRUCTURE FOUND IN THIS ENTRY IS THE RESTRAINED REMARK 3 MINIMIZED AVERAGE STRUCTURE: (SA)R. THIS IS OBTAINED BY REMARK 3 FIRST AVERAGING THE COORDINATES OF THE INDIVIDUAL 35 REMARK 3 DYNAMICAL SIMULATED ANNEALING SA STRUCTURES BEST FITTED TO REMARK 3 RESIDUES 1 - 105 OF HTRX AND RESIDUES 57 - 67 OF THE REMARK 3 PEPTIDE AND SUBJECTING THE RESULTING COORDINATES TO REMARK 3 RESTRAINED MINIMIZATION. THE LAST NUMBER COLUMN IN THIS REMARK 3 SET OF COORDINATES (THE B-FACTOR COLUMN IN X-RAY REMARK 3 STRUCTURES) GIVES THE AVERAGE RMS DIFFERENCE BETWEEN THE REMARK 3 INDIVIDUAL SA STRUCTURES AND THE MEAN STRUCTURE.
REMARK 4 REMARK 4 1CQH COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 27 30.03 -97.61 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CQG RELATED DB: PDB
REMARK 999 REMARK 999 SEQUENCE REMARK 999 THR AT POSITION 74 WAS FOUND BY WOLMAN ET AL., JOURNAL OF REMARK 999 BIOCHEMISTRY 263, 15506 (1988).
DBREF 1CQH A 2 105 UNP P10599 THIO_HUMAN 1 104 DBREF 1CQH B 59 71 UNP P27695 APEX1_HUMAN 58 70
SEQADV 1CQH ALA A 35 UNP P10599 CYS 34 ENGINEERED SEQADV 1CQH ALA A 62 UNP P10599 CYS 61 ENGINEERED SEQADV 1CQH ALA A 69 UNP P10599 CYS 68 ENGINEERED SEQADV 1CQH ALA A 73 UNP P10599 CYS 72 ENGINEERED SEQADV 1CQH THR A 74 UNP P10599 MET 73 CONFLICT
SEQRES 1 A 105 MET VAL LYS GLN ILE GLU SER LYS THR ALA PHE GLN GLU SEQRES 2 A 105 ALA LEU ASP ALA ALA GLY ASP LYS LEU VAL VAL VAL ASP SEQRES 3 A 105 PHE SER ALA THR TRP CYS GLY PRO ALA LYS MET ILE LYS SEQRES 4 A 105 PRO PHE PHE HIS SER LEU SER GLU LYS TYR SER ASN VAL SEQRES 5 A 105 ILE PHE LEU GLU VAL ASP VAL ASP ASP ALA GLN ASP VAL SEQRES 6 A 105 ALA SER GLU ALA GLU VAL LYS ALA THR PRO THR PHE GLN SEQRES 7 A 105 PHE PHE LYS LYS GLY GLN LYS VAL GLY GLU PHE SER GLY SEQRES 8 A 105 ALA ASN LYS GLU LYS LEU GLU ALA THR ILE ASN GLU LEU SEQRES 9 A 105 VAL SEQRES 1 B 13 PRO ALA THR LEU LYS ILE CYS SER TRP ASN VAL ASP GLY
HELIX 1 1 LYS A 8 ALA A 17 1 10 HELIX 2 2 GLY A 33 PHE A 42 1 10 HELIX 3 3 SER A 44 LYS A 48 5 5 HELIX 4 4 GLN A 63 ALA A 69 1 7 HELIX 5 5 LYS A 94 LEU A 104 1 11
SHEET 1 A 5 VAL A 2 ILE A 5 0 SHEET 2 A 5 ILE A 53 VAL A 57 1 N PHE A 54 O LYS A 3 SHEET 3 A 5 VAL A 23 PHE A 27 1 N VAL A 24 O ILE A 53 SHEET 4 A 5 THR A 76 LYS A 81 -1 N PHE A 80 O VAL A 23 SHEET 5 A 5 GLN A 84 SER A 90 -1 N PHE A 89 O PHE A 77
SSBOND 1 CYS A 32 CYS B 65 1555 1555 2.03
CISPEP 1 THR A 74 PRO A 75 0 -2.71
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000